Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
 1 Months Ended 3 Months Ended
Mar. 31, 2020
Mar. 31, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ (1,000) $ 35,849,811
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Change in fair value of derivative warrant liabilities (36,237,872)
Interest earned on marketable securities held in Trust Account (60,633)
Changes in operating assets and liabilities:    
Prepaid expenses (6,883)
Accounts payable and accrued expenses 1,000 95,747
Income taxes payable 2,233
Net cash used in operating activities (357,597)
Net Change in Cash (357,597)
Cash – Beginning of the period 950,537
Cash – End of the period 592,940
Non-Cash Financing Activities:    
Change in value of Class A common stock subject to possible redemption 35,849,810
Deferred offering costs paid directly by Sponsor in consideration for the issuance of Class B common stock 25,000
Deferred offering costs paid through promissory note – related party 19,074
Deferred offering costs included in accrued offering costs $ 30,000